Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease
Annals of Neurology · 2023-02 · 93 (2) · 317-329
DOI: 10.1002/ana.26517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 20.10.2022. Verfasst von Flavio Raschellà und 4 weiteren Autor:innen. Beteiligte Einrichtung: Onera Health, Eindhoven, the Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, REM Sleep Behavior Disorder. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Objectives
Rapid eye movement sleep behavior disorder (RBD) is a potentially harmful, often overlooked sleep disorder affecting up to 70% of Parkinson's disease patients. Current diagnosis relies on nocturnal video‐polysomnography, which is an expensive and cumbersome examination requiring specific clinical expertise. Here, we explored the use of wrist actigraphy to enable automatic RBD diagnoses in home settings.
Methods
A total of 26 Parkinson's disease patients underwent 2‐week home wrist actigraphy, followed by two in‐laboratory evaluations. Patients were classified as RBD versus non‐RBD based on dream enactment history and video‐polysomnography. We comprehensively characterized patients' movement patterns during sleep using actigraphic signals. We then trained machine learning classification algorithms to discriminate patients with or without RBD using the most relevant features. Classification performance was quantified with respect to clinical diagnosis, separately for in‐laboratory and at‐home recordings. Performance was further validated in a control group of non‐Parkinson's disease patients with other sleep conditions.
Results
To characterize RBD, actigraphic features extracted from both (1) individual movement episodes and (2) global nocturnal activity were critical. RBD patients were more active overall, and showed movements that were shorter, of higher magnitude, and more scattered in time. Using these features, our classification algorithms reached an accuracy of 92.9 ± 8.16% during in‐clinic tests. When validated on home recordings in Parkinson's disease patients, accuracy reached 100% over a 2‐week window, and was 94.4% in non‐Parkinson's disease control patients. Features showed robustness across tests and conditions.
Interpretation
These results open new perspectives for faster, cheaper, and more regular screening of sleep disorders, both for routine clinical practice and clinical trials. ANN NEUROL 2023;93:317–329
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Onera Health, Eindhoven, the Netherlands.
- Defitech Center for Interventional Neurotherapies (.NeuroRestore), Lausanne University Hospital and Ecole Polytechnique Féderale de Lausanne (EPFL), Lausanne, Switzerland.
- Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
- Institute of Digital Technologies for Personalized Healthcare (MedITech), University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland.
- Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
- Al Centro del Sonno, Venice, Italy.
ORCID-Profile: Eduardo Martin Moraud, Pietro-Luca Ratti
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Raschellà, F., Scafa, S., Puiatti, A., Martin Moraud, E., & Ratti, P. L. (2023). Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease. Annals of Neurology, 93(2), 317-329. https://doi.org/10.1002/ana.26517
Vancouver
Raschellà F, Scafa S, Puiatti A, Martin Moraud E, Ratti PL. Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease. Annals of Neurology. 2023;93(2):317-329. doi:10.1002/ana.26517
BibTeX
@article{Raschell2023,
author = {Raschellà, Flavio and Scafa, Stefano and Puiatti, Alessandro and Martin Moraud, Eduardo and Ratti, Pietro-Luca},
title = {Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease},
journal = {Annals of Neurology},
year = {2023},
volume = {93},
number = {2},
pages = {317--329},
doi = {10.1002/ana.26517}
}
EUVIMED